However, an increasing number of evidences showed that POSTN expressed in the cancer microenvironment was also associated with poor prognosis in various types of cancer such as non-small cell lung cancer [16], pancreatic cancer [17, 18], prostate cancer [19] as well as ovarian cancer [20, 21]. The gene discussed is POSTN; the disease is prostate carcinoma.